Document Code: SCF-GCA-MO-0001
Framework Basis: SCF-MULTI-OMIC
Status: Generated atlas draft for preclinical systems-mapping use
1. Purpose
To classify disease-relevant genes into SCF-operational classes using the SCF multi-omic framework so they can be mapped to fault tiers, biomarker panels, therapeutic roles, and translational assay systems. The atlas is anchored in the SCF omics layers of genomics, transcriptomics, epigenomics, proteomics, metabolomics, interactomics, connectomics, and biomechanicalomics, which the framework uses to identify mutation faults, expression collapse, immune tolerance loss, scaffold decay, oxidative imbalance, signal bottlenecks, neural desynchronization, and structural-phase failure.
2. SCF Multi-Omic Gene-Class Logic
The atlas uses five SCF fault domains as the primary organizing spine:
- Bioenergetic collapse
- ECM scaffold decay
- Immune circuit shift
- Neural desync
- Redox collapse
Each gene class is then evaluated through SCF translational functions:
- target specificity
- pharmacokinetic relevance
- metabolic efficiency relevance
- resistance-prevention relevance
- safety relevance
3. Atlas Structure
SCF Gene Class | Primary Omics Anchor | SCF Fault Tier Alignment | Core Biological Function | Example Marker Domain |
G1. Genomic Fault Drivers | Genomics | Origin / Tier Initiation | inherited or convergent mutation architecture | SNPs, variants |
G2. Transcript Collapse Regulators | Transcriptomics | Tier Propagation | expression suppression, splice dysregulation | RNA-seq, splice maps |
G3. Epigenomic Lockout Genes | Epigenomics | Persistence / Immune tolerance drift | methylation and histone-mediated lockout | methylome, chromatin marks |
G4. Proteostasis-ECM Scaffold Genes | Proteomics | Structural Tier | scaffold integrity, folding, adhesion | ECM proteins, chaperones |
G5. Metabolic Flux Controllers | Metabolomics | Bioenergetic Tier | ATP/cAMP, redox, mitochondrial throughput | ATP:cAMP, NAD+/NADH |
G6. Interactome Relay Nodes | Interactomics | Network Bottleneck Tier | PPI relay, signal overload, cross-talk | PPI hubs |
G7. Connectomic Rhythm Genes | Connectomics | Neural Timing Tier | vagal/limbic synchrony, circadian output | neural response-linked markers |
G8. Biomechanical Response Genes | Biomechanicalomics | Structural-Phase Tier | fascia tension, ECM force sensing, fibrosis | stiffness/integrin-linked markers |
G9. Immune Circuit Genes | Multi-omic | Immune Desync Tier | cytokine balance, T-cell state, tolerance | CD4/CD8, IL-2, IL-7, TNF-α, IFN-γ, Treg/Th17 |
G10. Xenobiotic/Viral Response Genes | Multi-omic | Viragenic / Mutagenic Drift Tier | toxicant-response, proviral-mimetic drift, host hijacking | CYP1A1, CYP1B1, ARNT, proto-oncogene drift metrics |
This structure is directly supported by the SCF omics-layered integration model and by the VECTIS-409 assay set, which explicitly names immune, metabolic, ECM-integrin, and AhR-activation panels as core analytical modules.
4. SCF GENE-CLASS ATLAS DETAIL
G1. Genomic Fault Drivers
Definition: Genes whose variants initiate susceptibility, pathway fragility, or convergent mutation faults.
SCF role in atlas: upstream etiopathogenic anchors.
Primary readouts: variant signatures, SNP burden, convergent mutation maps.
G2. Transcript Collapse Regulators
Definition: Genes whose altered transcription or splicing drives expression collapse and downstream loss of pathway fidelity.
SCF role in atlas: dynamic amplifiers of disease-state propagation.
Primary readouts: RNA-seq, splice maps, time-course expression collapse patterns.
G3. Epigenomic Lockout Genes
Definition: Genes controlled by methylation or histone-pattern shifts that produce immune tolerance loss, persistence, and non-responsiveness.
SCF role in atlas: chronicity and relapse-maintenance nodes.
Primary readouts: methylation panels, histone-state profiling.
G4. Proteostasis-ECM Scaffold Genes
Definition: Genes encoding ECM proteins, chaperones, adhesion regulators, and scaffold-maintenance factors.
SCF role in atlas: structural integrity and tissue communication regulators.
Primary readouts: ECM protein maps, chaperone maps, integrin-linked profiles. The SCF fault architecture explicitly links ECM scaffold decay and integrin-phase disruption to fibrosis and tissue miscommunication.
G5. Metabolic Flux Controllers
Definition: Genes governing mitochondrial output, ATP/cAMP coupling, redox control, and energetic reserve.
SCF role in atlas: core bioenergetic control class.
Primary readouts: ATP:cAMP, NAD+/NADH, lactate, mitochondrial ROS. SCF identifies ATP/cAMP exhaustion as a unifying metabolic trigger in multisystemic disease.
G6. Interactome Relay Nodes
Definition: Genes positioned at PPI hubs, relay junctions, and cross-talk bottlenecks.
SCF role in atlas: pathway-routing and system-drift nodes.
Primary readouts: PPI network centrality, relay-node failure, bottleneck stress signatures.
G7. Connectomic Rhythm Genes
Definition: Genes and gene-linked pathways associated with vagal, limbic, circadian, and neuroimmune synchronization.
SCF role in atlas: timing, behavioral, and circuit-fidelity regulators.
Primary readouts: connectomic coupling, circadian-linked transcriptional oscillation, vagal-response signatures. SCF maps neural desync to vagal-cAMP collapse and circadian/behavioral dysfunction.
G8. Biomechanical Response Genes
Definition: Genes involved in mechanotransduction, fascia tension response, ECM strain adaptation, and fibrosis signaling.
SCF role in atlas: structural-phase integrity class.
Primary readouts: fascia strain, ECM tension, stiffness-linked transcription, integrin-phase response. The framework uses biomechanicalomics to locate structural-phase failure such as fibrosis or tissue misfire.
G9. Immune Circuit Genes
Definition: Genes controlling cytokine tone, T-cell state transitions, lymphoid maintenance, and immune synchronization.
SCF role in atlas: inflammatory drift and immune recovery class.
Primary readouts: CD4/CD8, IL-2, IL-7, TNF-α, IFN-γ, Treg/Th17 markers. SCF defines immune circuit shift as a fault domain producing autoimmunity and chronic inflammation.
G10. Xenobiotic/Viral Response Genes
Definition: Genes activated in toxicant sensing, proviral-like hijacking, adaptive stress, and mutagenic drift.
SCF role in atlas: viragenic and xenobiotic convergence class.
Primary readouts: CYP1A1, CYP1B1, ARNT, proto-oncogene drift metrics. In VECTIS-409, these markers define the AhR gene activation profile within the HIV–TCDD convergence program.
5. SCF Fault-Tier Mapping Matrix
SCF Fault Domain | Dominant Gene Classes | Expected Systemic Output |
Bioenergetic Collapse | G5, G6, G7 | regenerative loss, low reserve, metabolic drift |
ECM Scaffold Decay | G4, G8 | fibrosis, tissue miscommunication, impaired repair |
Immune Circuit Shift | G3, G9, G10 | chronic inflammation, immune instability, tolerance collapse |
Neural Desync | G7, G9 | circadian dysfunction, neuroimmune instability |
Redox Collapse | G5, G10 | mitochondrial uncoupling, signaling breakdown |
This is a direct operationalization of the SCF fault architecture table in the pathophysiology protocol.
6. SCF Therapeutic Relevance Layer
The pathophysiology protocol links these gene classes to therapeutic reconstruction targets:
- restore cell energy
- rebuild tissues
- remove toxic stress
- balance the immune system
- re-sync brain-body signals
- deploy smart delivery
Accordingly, the atlas maps classes to SCF therapeutic roles as follows:
Gene Class | Primary SCF Therapeutic Role |
G1 | Target-Specific Modulator |
G2 | Target-Specific Modulator |
G3 | Safety Harmonizer / Target Modulator |
G4 | Safety Harmonizer |
G5 | Metabolic Regulator |
G6 | Target Modulator / Resistance Prevention support |
G7 | Metabolic Regulator / Timing Modulator |
G8 | Safety Harmonizer / Structural Restorative |
G9 | Target Modulator / Safety Harmonizer |
G10 | Target Modulator / Resistance Prevention support |
These role categories are consistent with the SCF role-assignment framework for target-specific modulators, bioavailability enhancers, metabolic regulators, and safety harmonizers.
7. Atlas-to-Assay Deployment
For preclinical deployment, the atlas can be operationalized through the existing VECTIS-409 assay and modeling system:
Atlas Module | Recommended Assay/Platform |
Immune Circuit Gene Module | V409-A11 Fault-Tier Immunogram |
Metabolic Flux Gene Module | V409-A12 Mito-Collapse Panel |
ECM/Structural Gene Module | V409-A13 ECM-Integrin Disruption Assay |
Xenobiotic/Viral Response Gene Module | V409-A14 AhR Gene Activation Profile |
Cross-omic simulation | V409-SYS-1 to V409-SYS-4 |
These assay and modeling modules are already named in the VECTIS-409 identity package and align well with an SCF gene-class atlas implementation path.
8. SCF Synergy Evaluation Layer
Each gene class should be evaluated under the five SCF synergy metrics:
- TSSM for resistance-prevention durability
- HSV-F² for metabolic coherence
- SV-EQ for target specificity
- MGIS for geometry/PK fit
- SPCI for safety/tolerance
This means the atlas is not only a classification tool but also a scoring scaffold for candidate APIs, delivery systems, and multi-target stacks.
9. Recommended Standard Output Format for Each Gene-Class Record
For each gene or gene family entered into the atlas, use this minimum record schema:
- Gene / Gene Family
- SCF Gene Class
- Primary Omics Layer
- Secondary Omics Layers
- Fault Tier Alignment
- Mechanistic Role
- Dominant Biomarker Readouts
- Relevant Assay Panel
- Therapeutic Vulnerability
- SCF Role Assignment
- PCR Braid Relevance: Preventative / Curative / Restorative
- SEF Metric Priority: TSSM / HSV-F² / SV-EQ / MGIS / SPCI
- Regulatory Utility: discovery / preclinical / IND biomarker / clinical stratification
This structure is consistent with the API-discovery requirement for omics breakdown, biomarker panels, ADMET framing, and transition to formulation, synergy matrix, and IND/NDA/BLA pathways.
10. SCF Conclusion
The SCF-MULTI-OMIC framework supports a gene-class atlas organized around cross-omic failure states rather than around isolated genes. In this schema, genes are grouped by their role in mutation initiation, transcript collapse, epigenetic lockout, ECM/proteostasis failure, metabolic breakdown, interactome bottlenecking, neural desynchronization, biomechanical failure, immune-circuit drift, and xenobiotic/viral-response convergence. That architecture is fully compatible with SCF fault mapping, biomarker panel design, synergy scoring, and translational therapeutic engineering.
11. Limitation Statement
Your files provide the SCF multi-omic architecture and assay logic, but they do not provide a canonical, pre-filled list of specific gene symbols for each class. So this atlas is a validated framework-level gene-class model, not yet a disease-specific gene inventory.
12. Next Recommended Expansion
The next rigorous step is to convert this atlas into one of three disease-specific versions:
- SCF GENE-CLASS ATLAS — HIV/AEIC
- SCF GENE-CLASS ATLAS — TCDD/Xenobiotic Collapse
- SCF GENE-CLASS ATLAS — Pan-Regenerative Multi-System Failure
I can build one of those next as a full gene-symbol table with biomarkers, assay mapping, and SCF role assignment.
Master Registry Index: SCF-GCA-MO-0001 | SCF-SEF-MD-0001 | SCF-PP-UVT-0001 | SCF-API-DP-0001 | SCF-CRD-WORKFLOW-0001 | SCF-IDX-V409-PIP-0001